Femme et Homme
- | Pays :
- Spain
- Germany
- France
- Les 7 autres...
- | Organes : -
- | Spécialités : -
Extrait
This study consists of a 4 week run-in period with a Ca based phosphate binder and 12 weeks treatment period by MCI-196 or placebo, (both on Ca based phosphate binder). During the treatment period, MCI-196 or placebo will be titrated every 3 weeks.
Critère d'inclusion
- chronic kidney disease ,dialysis ,Hyperphosphatemia